{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:59:44Z","timestamp":1791467984657,"version":"4.3.4"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.neuroscience.2026.06.032","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T15:16:36Z","timestamp":1782314196000},"page":"10-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeting of RhoA-ROCK pathway activators and linked molecular signaling in Alzheimer\u2019s disease: The paving dawn for future therapy"],"prefix":"10.1016","volume":"611","author":[{"given":"Haydar M.","family":"Al-kuraishy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esraa Hammadi","family":"Fahad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0759-8298","authenticated-orcid":false,"given":"Majid S.","family":"Jabir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayyadah F.","family":"Rafeeq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghassan M.","family":"Sulaiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibtissem Ben","family":"Amara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali K.","family":"Albuhadily","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali I.","family":"Al-Gareeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.neuroscience.2026.06.032_b0005","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3390\/cells14020089","article-title":"Molecular mechanisms of Alzheimer\u2019s disease induced by amyloid-\u03b2 and tau phosphorylation along with RhoA activity: perspective of RhoA\/Rho-associated protein kinase inhibitors for neuronal therapy","volume":"14","author":"Ahn","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.neuroscience.2026.06.032_b0010","doi-asserted-by":"crossref","DOI":"10.1002\/alz.066991","article-title":"Spatial dysregulation of Rho GTPases in Alzheimer\u2019s disease brain in human and in transgenic mouse model","volume":"18","author":"Akhtar","year":"2022","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neuroscience.2026.06.032_b0015","doi-asserted-by":"crossref","DOI":"10.1177\/26331055221109254","article-title":"VEGF paradoxically reduces cerebral blood flow in Alzheimer\u2019s disease mice","volume":"17","author":"Ali","year":"2022","journal-title":"Neurosci. Insights"},{"issue":"3","key":"10.1016\/j.neuroscience.2026.06.032_b0020","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s10787-023-01163-7","article-title":"Long-term use of metformin and Alzheimer\u2019s disease: beneficial or detrimental effects","volume":"31","author":"Al-Kuraishy","year":"2023","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.neuroscience.2026.06.032_b0025","article-title":"Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: the guardian angle","volume":"14","author":"Al-Kuraishy","year":"2024","journal-title":"Ageing Res. Rev."},{"issue":"484","key":"10.1016\/j.neuroscience.2026.06.032_b0030","article-title":"Role of RhoA-ROCK signaling inhibitor fasudil in Alzheimer disease","volume":"27","author":"Al-Kuraishy","year":"2025","journal-title":"Behav. Brain Res."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.06.032_b0035","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1515\/revneuro-2015-0041","article-title":"Angiotensin II-triggered kinase signaling cascade in the central nervous system","volume":"27","author":"Bali","year":"2016","journal-title":"Rev. Neurosci."},{"issue":"168","key":"10.1016\/j.neuroscience.2026.06.032_b0040","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.brainresbull.2020.12.010","article-title":"Aerobic exercise training decreases cognitive impairment caused by demyelination by regulating ROCK signaling pathway in aging mice","volume":"1","author":"Bao","year":"2021","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuroscience.2026.06.032_b0045","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s44161-021-00014-4","article-title":"Blood-brain barrier link to human cognitive impairment and Alzheimer's disease","volume":"1","author":"Barisano","year":"2022","journal-title":"Nat. Cardiovasc. Res."},{"issue":"12","key":"10.1016\/j.neuroscience.2026.06.032_b0050","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1212\/WNL.0000000000207779","article-title":"What is the role of the rho-ROCK pathway in neurologic disorders?","volume":"101","author":"Benarroch","year":"2023","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.neuroscience.2026.06.032_b0055","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1080\/21541248.2017.1413496","article-title":"Acute compressive stress activates RHO\/ROCK-mediated cellular processes","volume":"11","author":"Boyle","year":"2020","journal-title":"Small GTPases"},{"issue":"414","key":"10.1016\/j.neuroscience.2026.06.032_b0060","article-title":"Role of RhoA\/ROCK signaling in Alzheimer\u2019s disease","volume":"24","author":"Cai","year":"2021","journal-title":"Behav. Brain Res."},{"issue":"32","key":"10.1016\/j.neuroscience.2026.06.032_b0065","article-title":"Distinct dual roles of p-Tyr42 RhoA GTPase in tau phosphorylation and ATP citrate lyase activation upon different A\u03b2 concentrations","volume":"1","author":"Cap","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.neuroscience.2026.06.032_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101420","article-title":"Can platelet activation result in increased plasma A\u03b2 levels and contribute to the pathogenesis of Alzheimer's disease?","volume":"71","author":"Carbone","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.neuroscience.2026.06.032_b0075","article-title":"Small GTPases control macropinocytosis of amyloid precursor protein and cleavage to amyloid-\u03b2","author":"Chiu","year":"2024","journal-title":"Heliyon."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.06.032_b0080","doi-asserted-by":"crossref","first-page":"17713","DOI":"10.1038\/s41598-017-18042-1","article-title":"VEGFR2 alteration in Alzheimer\u2019s disease","volume":"7","author":"Cho","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuroscience.2026.06.032_b0085","doi-asserted-by":"crossref","unstructured":"De Filippis, D., Cipriano, M., Esposito, G., Scuderi, C., Steardo, L., Iuvone, T., 2010. Are anti-angiogenic drugs useful in neurodegenerative disorders?. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders). Dec 1;9(6):807-12.","DOI":"10.2174\/187152710793237485"},{"issue":"3","key":"10.1016\/j.neuroscience.2026.06.032_b0090","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/bjophthalmol-2020-318452","article-title":"Treatments for dry age-related macular degeneration: therapeutic avenues, clinical trials and future directions","volume":"106","author":"de Guimaraes","year":"2022","journal-title":"Br. J. Ophthalmol."},{"issue":"7964","key":"10.1016\/j.neuroscience.2026.06.032_b0095","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41586-023-06120-6","article-title":"Myelin dysfunction drives amyloid-\u03b2 deposition in models of Alzheimer\u2019s disease","volume":"618","author":"Depp","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.06.032_b0100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s43556-021-00036-1","article-title":"G-protein coupled receptor, PI3K and Rho signaling pathways regulate the cascades of Tau and amyloid-\u03b2 in Alzheimer\u2019s disease","volume":"2","author":"Desale","year":"2021","journal-title":"Mol. Biomed."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.06.032_b0105","first-page":"9","article-title":"Hypertension enhances A\u03b2-induced neurovascular dysfunction, promotes \u03b2-secretase activity, and leads to amyloidogenic processing of APP","volume":"29","author":"Faraco","year":"2015","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.06.032_b0110","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/WAD.0000000000000420","article-title":"\u03b2-Amyloid orchestrates factor XII and platelet activation leading to endothelial dysfunction and abnormal fibrinolysis in Alzheimer disease","volume":"35","author":"Garc\u00eda-Mej\u00eda","year":"2021","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"11","key":"10.1016\/j.neuroscience.2026.06.032_b0115","doi-asserted-by":"crossref","first-page":"9290","DOI":"10.1074\/jbc.M211899200","article-title":"Platelet-derived growth factor induces the beta-gamma-secretase-mediated cleavage of Alzheimer's amyloid precursor protein through a Src-Rac-dependent pathway","volume":"278","author":"Gianni","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.neuroscience.2026.06.032_b0120","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.3390\/cells12101367","article-title":"The RhoA-ROCK1\/ROCK2 pathway exacerbates inflammatory signaling in immortalized and primary microglia","volume":"12","author":"Glotfelty","year":"2023","journal-title":"Cells."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.06.032_b0125","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3390\/genes14020272","article-title":"Effect of the Rho-kinase\/ROCK signaling pathway on cytoskeleton components","volume":"14","author":"Guan","year":"2023","journal-title":"Genes"},{"key":"10.1016\/j.neuroscience.2026.06.032_b0130","doi-asserted-by":"crossref","unstructured":"Guo, M.F., Zhang, H.Y., Li, Y.H., Gu, Q.F., Wei, W.Y., Wang, Y.Y., Zhang, X.J., Liu, X.Q., Song, L.J., Chai, Z., Yu, J.Z., Ma, C.G., 2020. Fasudil inhibits the activation of microglia and astrocytes of transgenic Alzheimer's disease mice via the downregulation of TLR4\/Myd88\/NF-\u03baB pathway. J. Neuroimmunol. 346, 577284.","DOI":"10.1016\/j.jneuroim.2020.577284"},{"issue":"4","key":"10.1016\/j.neuroscience.2026.06.032_b0135","doi-asserted-by":"crossref","first-page":"651","DOI":"10.31083\/j.jin.2020.04.243","article-title":"Fasudil reduces \u03b2-amyloid levels and neuronal apoptosis in APP\/PS1 transgenic mice via inhibition of the Nogo-A\/NgR\/RhoA signaling axis","volume":"19","author":"Guo","year":"2020","journal-title":"J. Integr. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.06.032_b0140","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neurobiolaging.2019.12.009","article-title":"Rho-kinase ROCK inhibitors reduce oligomeric tau protein","volume":"89","author":"Hamano","year":"2020","journal-title":"Neurobiol. Aging"},{"issue":"19","key":"10.1016\/j.neuroscience.2026.06.032_b0145","article-title":"The role of small GTPases in Alzheimer's disease tau pathologies","volume":"25","author":"Hoegy","year":"2025","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.06.032_b0150","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3233\/JAD-2010-1203","article-title":"Altered distribution of RhoA in Alzheimer\u2019s disease and AbetaPP overexpressing mice","volume":"19","author":"Huesa","year":"2010","journal-title":"J. Alzheimers Dis."},{"issue":"5","key":"10.1016\/j.neuroscience.2026.06.032_b0155","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/pin.12530","article-title":"Pathogenetic significance and possibility as a therapeutic target of platelet-derived growth factor","volume":"67","author":"Ishii","year":"2017","journal-title":"Pathol. Int."},{"issue":"191","key":"10.1016\/j.neuroscience.2026.06.032_b0160","article-title":"Upregulation of integrin beta-3 in astrocytes upon Alzheimer's disease progression in the 5xFAD mouse model","volume":"1","author":"Ivanova","year":"2024","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.06.032_b0165","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jphs.2020.06.007","article-title":"TLR4-TAK1-p38 MAPK pathway and HDAC6 regulate the expression of sigma-1 receptors in rat primary cultured microglia","volume":"144","author":"Iwamoto","year":"2020","journal-title":"J. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.06.032_b0170","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13041-020-00673-7","article-title":"The VEGF inhibitor vatalanib regulates AD pathology in 5xFAD mice","volume":"13","author":"Jeon","year":"2020","journal-title":"Mol. Brain"},{"issue":"5\u20136","key":"10.1016\/j.neuroscience.2026.06.032_b0175","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1080\/21541248.2020.1840889","article-title":"Regulation and functions of the RhoA regulatory guanine nucleotide exchange factor GEF-H1","volume":"12","author":"Joo","year":"2021","journal-title":"Small GTPases"},{"issue":"197","key":"10.1016\/j.neuroscience.2026.06.032_b0180","article-title":"Metformin in Alzheimer\u2019s disease: an overview of potential mechanisms, preclinical and clinical findings","volume":"1","author":"Khezri","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuroscience.2026.06.032_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102514","article-title":"Sleep disorders and risk of Alzheimer's disease: a two-way road","volume":"101","author":"Lacerda","year":"2024","journal-title":"Ageing Res. Rev."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.06.032_b0190","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1038\/s41467-023-37304-3","article-title":"An aging, pathology burden, and glial senescence buildup hypothesis for late-onset Alzheimer's disease","volume":"14","author":"Lau","year":"2023","journal-title":"Nat. Commun."},{"issue":"15","key":"10.1016\/j.neuroscience.2026.06.032_b0195","article-title":"Neuroprotective effect of angiotensin II receptor blockers on the risk of incident Alzheimer\u2019s disease: a nationwide population-based cohort study","volume":"6","author":"Lee","year":"2023","journal-title":"Front. Aging Neurosci."},{"issue":"328","key":"10.1016\/j.neuroscience.2026.06.032_b0200","article-title":"Therapeutic potential of Lingjiao Gouteng decoction in acute alcohol intoxication and alcohol-induced brain injury involving the RhoA\/ROCK2\/NF-\u03baB signaling pathway","volume":"28","author":"Li","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.neuroscience.2026.06.032_b0205","doi-asserted-by":"crossref","unstructured":"Lilja, J., Ivaska, J., 2018. Integrin activity in neuronal connectivity. J. Cell Sci. Jun 15;131(12):jcs212803.","DOI":"10.1242\/jcs.212803"},{"issue":"10","key":"10.1016\/j.neuroscience.2026.06.032_b0210","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3389\/fneur.2019.00293","article-title":"ROCK-ALS: protocol for a randomized, placebo-controlled, double-blind phase IIa trial of safety, tolerability and efficacy of the rho kinase (ROCK) inhibitor fasudil in amyotrophic lateral sclerosis","volume":"27","author":"Lingor","year":"2019","journal-title":"Front. Neurol."},{"issue":"7","key":"10.1016\/j.neuroscience.2026.06.032_b0215","doi-asserted-by":"crossref","first-page":"618","DOI":"10.2174\/1567205015666180110110321","article-title":"Amyloid-\u03b2 inhibits PDGF\u03b2 receptor activation and prevents PDGF-BB-induced neuroprotection","volume":"15","author":"Liu","year":"2018","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neuroscience.2026.06.032_b0220","doi-asserted-by":"crossref","unstructured":"Lopez-Lopez, A., Villar-Cheda, B., Quijano, A., Garrido-Gil, P., Garcia-Garrote, M., D\u00edaz-Ruiz, C., Mu\u00f1oz, A., Labandeira-Garcia, J.L., 2021. NADPH-oxidase, rho-kinase and autophagy mediate the (pro) renin-induced pro-inflammatory microglial response and enhancement of dopaminergic neuron death. Antioxidants (Basel, Switzerland). Aug 25;10(9):1340-.","DOI":"10.3390\/antiox10091340"},{"key":"10.1016\/j.neuroscience.2026.06.032_b0225","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s11011-021-00709-4","article-title":"RhoA\/ROCK signaling pathway and astrocytes in ischemic stroke","volume":"36","author":"Lu","year":"2021","journal-title":"Metab. Brain Dis."},{"issue":"233","key":"10.1016\/j.neuroscience.2026.06.032_b0230","article-title":"Metformin reduces fibrosis factors in insulin resistant and hypertrophied adipocyte via integrin\/ERK, collagen VI, apoptosis, and necrosis reduction","volume":"15","author":"Malekpour-Dehkordi","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.neuroscience.2026.06.032_b0235","first-page":"1","article-title":"Therapeutic implications of glycogen synthase kinase-3\u03b2 in Alzheimer\u2019s disease: a novel therapeutic target","volume":"30","author":"Mandlik","year":"2022","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.06.032_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104871","article-title":"ROCK2 inhibition: a futuristic approach for the management of Alzheimer's disease","volume":"142","author":"Mani","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"12","key":"10.1016\/j.neuroscience.2026.06.032_b0245","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.2174\/1567205015666180801111033","article-title":"Anti-\u03b14\u03b21 integrin antibodies attenuated brain inflammatory changes in a mouse model of Alzheimer's disease","volume":"15","author":"Manocha","year":"2018","journal-title":"Curr. Alzheimer Res."},{"issue":"225","key":"10.1016\/j.neuroscience.2026.06.032_b0250","article-title":"Emerging targets in drug discovery against neurodegenerative diseases: control of synapsis disfunction by the RhoA\/ROCK pathway","volume":"5","author":"Martin-Camara","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.neuroscience.2026.06.032_b0255","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac083","article-title":"Emerging insights into synapse dysregulation in Alzheimer\u2019s disease","author":"Mart\u00ednez-Serra","year":"2022","journal-title":"Brain Commun."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.06.032_b0260","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3390\/cimb47020124","article-title":"RhoA\/ROCK\/GSK3\u03b2 signaling: a keystone in understanding Alzheimer's disease","volume":"47","author":"Medd","year":"2025","journal-title":"Curr. Issues Mol. Biol."},{"issue":"9","key":"10.1016\/j.neuroscience.2026.06.032_b0265","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/j.cellsig.2013.05.023","article-title":"Involvement of small GTPase RhoA in the regulation of superoxide production in BV2 cells in response to fibrillar A\u03b2 peptides","volume":"25","author":"Moon","year":"2013","journal-title":"Cell. Signal."},{"issue":"237","key":"10.1016\/j.neuroscience.2026.06.032_b0270","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.bbr.2012.09.043","article-title":"Behavioral effects of Rho GTPase modulation in a model of Alzheimer's disease","volume":"15","author":"Musilli","year":"2013","journal-title":"Behav. Brain Res."},{"issue":"288","key":"10.1016\/j.neuroscience.2026.06.032_b0275","article-title":"Imatinib mesylate inhibits androgen-independent PC-3 cell viability, proliferation, migration, and tumor growth by targeting platelet-derived growth factor receptor-\u03b1","volume":"1","author":"Nayeem","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.neuroscience.2026.06.032_b0280","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.92755.3.sa3","article-title":"Rho GTPase signaling and mDia facilitate endocytosis via presynaptic actin","author":"Oevel","year":"2024","journal-title":"Elife"},{"key":"10.1016\/j.neuroscience.2026.06.032_b0285","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/brain\/awm260","article-title":"The beta-amyloid protein of Alzheimer\u2019s disease increases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanism","volume":"131","author":"Petratos","year":"2008","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.06.032_b0290","doi-asserted-by":"crossref","first-page":"12055","DOI":"10.1038\/s41598-019-48538-x","article-title":"Blockade of \u03b14 integrins reduces leukocyte\u2013endothelial interactions in cerebral vessels and improves memory in a mouse model of Alzheimer\u2019s disease","volume":"9","author":"Pietronigro","year":"2019","journal-title":"Sci. Rep."},{"issue":"15","key":"10.1016\/j.neuroscience.2026.06.032_b0295","doi-asserted-by":"crossref","first-page":"5398","DOI":"10.3390\/ijms21155398","article-title":"RhoA\/ROCK pathway activation is regulated by AT1 receptor and participates in smooth muscle migration and dedifferentiation via promoting actin cytoskeleton polymerization","volume":"21","author":"Qi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.06.032_b0300","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3934\/Neuroscience.2025032","article-title":"Neuropsychiatric symptoms in mild cognitive impairment and early Alzheimer's disease: clinical pattern and diagnostic implications","volume":"12","author":"Raphael","year":"2025","journal-title":"AIMS Neurosci."},{"key":"10.1016\/j.neuroscience.2026.06.032_b0305","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000512","article-title":"Late-onset vs nonmendelian early-onset Alzheimer disease: a distinction without a difference?","author":"Reitz","year":"2020","journal-title":"Neurology Genetics"},{"key":"10.1016\/j.neuroscience.2026.06.032_b0310","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1038\/srep02053","article-title":"VEGF significantly restores impaired memory behavior in Alzheimer\u2019s mice by improvement of vascular survival","volume":"3","author":"Religa","year":"2013","journal-title":"Sci. Rep."},{"issue":"13","key":"10.1016\/j.neuroscience.2026.06.032_b0315","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2147\/DDDT.S191617","article-title":"Endostatin attenuates PDGF-BB-or TGF-\u03b21-induced HSCs activation via suppressing RhoA\/ROCK1 signal pathways","volume":"11","author":"Ren","year":"2019","journal-title":"Drug Des. Devel. Ther."},{"issue":"8","key":"10.1016\/j.neuroscience.2026.06.032_b0320","doi-asserted-by":"crossref","first-page":"10984","DOI":"10.1096\/fj.202000550RR","article-title":"Activation of FAK\/Rac1\/Cdc42\u2010GTPase signaling ameliorates impaired microglial migration response to A\u03b242 in triggering receptor expressed on myeloid cells 2 loss\u2010of\u2010function murine models","volume":"34","author":"Rong","year":"2020","journal-title":"FASEB J."},{"issue":"17","key":"10.1016\/j.neuroscience.2026.06.032_b0325","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1021\/acschemneuro.3c00486","article-title":"Oxidative stress occurs prior to amyloid A\u03b2 plaque formation and tau phosphorylation in Alzheimer\u2019s disease: role of glutathione and metal ions","volume":"14","author":"Roy","year":"2023","journal-title":"ACS Chem. Nerosci."},{"issue":"5","key":"10.1016\/j.neuroscience.2026.06.032_b0330","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s11357-020-00231-y","article-title":"Brain angiotensin II and angiotensin IV receptors as potential Alzheimer\u2019s disease therapeutic targets","volume":"42","author":"Royea","year":"2020","journal-title":"Geroscience."},{"issue":"6","key":"10.1016\/j.neuroscience.2026.06.032_b0335","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1161\/HYPERTENSIONAHA.119.14431","article-title":"AT2R\u2019s (angiotensin II type 2 receptor\u2019s) role in cognitive and cerebrovascular deficits in a mouse model of Alzheimer disease","volume":"75","author":"Royea","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.neuroscience.2026.06.032_b0340","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neulet.2015.09.025","article-title":"Shedding of soluble platelet-derived growth factor receptor-beta from human brain pericytes","volume":"607","author":"Sagare","year":"2015","journal-title":"Neurosci. Lett."},{"issue":"5","key":"10.1016\/j.neuroscience.2026.06.032_b0345","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1208\/s12249-021-02072-0","article-title":"Development of imatinib mesylate-loaded liposomes for nose to brain delivery: in vitro and in vivo evaluation","volume":"22","author":"Saka","year":"2021","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"10.1016\/j.neuroscience.2026.06.032_b0350","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.3233\/JAD-142544","article-title":"Endostatin level in cerebrospinal fluid of patients with Alzheimer's disease","volume":"44","author":"Salza","year":"2015","journal-title":"J. Alzheimers Dis."},{"issue":"358","key":"10.1016\/j.neuroscience.2026.06.032_b0355","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.atherosclerosis.2022.08.012","article-title":"Role of RhoA and Rho-associated kinase in phenotypic switching of vascular smooth muscle cells: implications for vascular function","volume":"1","author":"Sawma","year":"2022","journal-title":"Atherosclerosis"},{"issue":"9","key":"10.1016\/j.neuroscience.2026.06.032_b0360","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.3390\/cells11091520","article-title":"RhoA signaling in neurodegenerative diseases","volume":"11","author":"Schmidt","year":"2022","journal-title":"Cells."},{"issue":"6","key":"10.1016\/j.neuroscience.2026.06.032_b0365","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/13543784.2020.1763953","article-title":"Risuteganib\u2014a novel integrin inhibitor for the treatment of non-exudative (dry) age-related macular degeneration and diabetic macular edema","volume":"29","author":"Shaw","year":"2020","journal-title":"Expert Opin. Invest. Drugs"},{"issue":"62","key":"10.1016\/j.neuroscience.2026.06.032_b0375","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.mam.2018.01.006","article-title":"PDGF\/PDGFR axis in the neural systems","volume":"1","author":"Sil","year":"2018","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.neuroscience.2026.06.032_b0380","doi-asserted-by":"crossref","unstructured":"Singh, A., 2025. ROCK inhibitors. InMastering DMEK and PDEK: Thin Membrane Endothelial Keratoplasty Feb 25 (pp. 195-210). Singapore: Springer Nature Singapore.","DOI":"10.1007\/978-981-97-3469-6_18"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.06.032_b0385","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s42003-022-03180-8","article-title":"Characterisation of PDGF-BB: PDGFR\u03b2 signalling pathways in human brain pericytes: evidence of disruption in Alzheimer\u2019s disease","volume":"5","author":"Smyth","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.neuroscience.2026.06.032_b0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.xinn.2023.100380","article-title":"A single-cell transcriptomic atlas of exercise-induced anti-inflammatory and geroprotective effects across the body","author":"Sun","year":"2023","journal-title":"The Innovation."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.06.032_b0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10753-022-01721-1","article-title":"Neuroinflammation in Alzheimer\u2019s disease: current progress in molecular signaling and therapeutics","volume":"46","author":"Thakur","year":"2023","journal-title":"Inflammation"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.06.032_b0400","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s13311-021-01146-y","article-title":"Neuropathology of Alzheimer's disease","volume":"19","author":"Trejo-Lopez","year":"2023","journal-title":"Neurotherapeutics"},{"issue":"105","key":"10.1016\/j.neuroscience.2026.06.032_b0410","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.neurobiolaging.2021.04.025","article-title":"Alzheimer's disease neuroimaging initiative. Regional relationships between CSF VEGF levels and Alzheimer's disease brain biomarkers and cognition","volume":"1","author":"Tubi","year":"2021","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.06.032_b0415","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41582-022-00749-z","article-title":"Synaptic degeneration in Alzheimer disease","volume":"19","author":"Tzioras","year":"2023","journal-title":"Nat. Rev. Neurol."},{"issue":"12","key":"10.1016\/j.neuroscience.2026.06.032_b0420","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.4103\/1673-5374.335827","article-title":"Advantages of Rho-associated kinases and their inhibitor fasudil for the treatment of neurodegenerative diseases","volume":"17","author":"Wang","year":"2022","journal-title":"Neural Regen. Res."},{"issue":"8","key":"10.1016\/j.neuroscience.2026.06.032_b0425","first-page":"635","article-title":"RhoA\/ROCK pathway involved in effects of sanjiao acupuncture on learning and memory and synaptic plasticity in Alzheimer's disease mice","volume":"46","author":"Wang","year":"2021","journal-title":"Zhen ci yan jiu= Acupuncture Res."},{"issue":"16","key":"10.1016\/j.neuroscience.2026.06.032_b0430","article-title":"Protocol for a randomized, placebo-controlled, double-blind phase IIa study of the safety, tolerability, and symptomatic efficacy of the ROCK-inhibitor Fasudil in patients with Parkinson\u2019s disease (ROCK-PD)","volume":"14","author":"Wolff","year":"2024","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuroscience.2026.06.032_b0435","first-page":"1","article-title":"SAFE-ROCK: a phase I trial of an oral application of the ROCK inhibitor fasudil to assess bioavailability, safety, and tolerability in healthy participants","volume":"28","author":"Wolff","year":"2024","journal-title":"CNS Drugs"},{"issue":"4","key":"10.1016\/j.neuroscience.2026.06.032_b0440","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s40263-024-01070-7","article-title":"SAFE-ROCK: a phase I trial of an oral application of the ROCK inhibitor fasudil to assess bioavailability, safety, and tolerability in healthy participants","volume":"38","author":"Wolff","year":"2024","journal-title":"CNS Drugs"},{"issue":"6","key":"10.1016\/j.neuroscience.2026.06.032_b0445","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/acel.12521","article-title":"Amyloid \u03b2\u2010induced astrogliosis is mediated by \u03b21\u2010integrin via NADPH oxidase 2 in Alzheimer's disease","volume":"15","author":"Wyssenbach","year":"2016","journal-title":"Aging Cell"},{"key":"10.1016\/j.neuroscience.2026.06.032_b0450","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.755164","article-title":"Inhibition of rho kinase by fasudil ameliorates cognition impairment in APP\/PS1 transgenic mice via modulation of gut microbiota and metabolites","volume":"13","author":"Yan","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.06.032_b0455","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0197-4580(03)00111-8","article-title":"Co-accumulation of vascular endothelial growth factor with \u03b2-amyloid in the brain of patients with Alzheimer\u2019s disease","volume":"25","author":"Yang","year":"2004","journal-title":"Neurobiol. Aging"},{"issue":"18","key":"10.1016\/j.neuroscience.2026.06.032_b0460","article-title":"Role of Rho-associated kinases and their inhibitor fasudil in neurodegenerative diseases","volume":"19","author":"Ye","year":"2024","journal-title":"Front. Neurosci."},{"issue":"29","key":"10.1016\/j.neuroscience.2026.06.032_b0465","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202002566","article-title":"Ligand diffusion enables force\u2010independent cell adhesion via activating \u03b15\u03b21 integrin and initiating rac and RhoA signaling","volume":"32","author":"Yu","year":"2020","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.06.032_b0470","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/14728222.2020.1712593","article-title":"Targeting Rho-associated coiled-coil forming protein kinase (ROCK) in cardiovascular fibrosis and stiffening","volume":"24","author":"Yu","year":"2020","journal-title":"Expert Opin. Ther. Targets"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.06.032_b0475","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11357-023-00923-1","article-title":"Endocytosis and Alzheimer\u2019s disease","volume":"46","author":"Zadka","year":"2024","journal-title":"GeroScience."},{"issue":"7","key":"10.1016\/j.neuroscience.2026.06.032_b0480","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3390\/cells13070642","article-title":"Neuroprotection of cholinergic neurons with a tau aggregation inhibitor and rivastigmine in an Alzheimer\u2019s-like tauopathy mouse model","volume":"13","author":"Zadrozny","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.neuroscience.2026.06.032_b0485","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12987-025-00638-9","article-title":"Sleep disorders and Alzheimer\u2019s disease: relationship and mechanisms involving neuroinflammation, orexin and A\u03b2","volume":"22","author":"Zhang","year":"2025","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.06.032_b0490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-023-00388-4","article-title":"Blockage of VEGF function by bevacizumab alleviates early-stage cerebrovascular dysfunction and improves cognitive function in a mouse model of Alzheimer\u2019s disease","volume":"13","author":"Zhang","year":"2024","journal-title":"Translational Neurodegeneration."},{"issue":"6","key":"10.1016\/j.neuroscience.2026.06.032_b0495","article-title":"Rock inhibitors in Alzheimer's disease","volume":"20","author":"Zheng","year":"2025","journal-title":"Front. Aging"},{"key":"10.1016\/j.neuroscience.2026.06.032_b0500","doi-asserted-by":"crossref","unstructured":"Zhu, Z., Lu, J., Wang, S., Peng, W., Yang, Y., Chen, C., Zhou, X., Yang, X., Xin, W., Chen, X., Pi, J., Yin, W., Yao, L., Pi, R., 2022. Acrolein, an endogenous aldehyde induces synaptic dysfunction in vitro and in vivo: Involvement of RhoA\/ROCK2 pathway. Aging Cell. Apr;21(4):e13587. doi: 10.1111\/acel.13587. Epub 2022 Mar 22. Erratum in: Aging Cell. 2023 Oct;22(10):e13945. doi: 10.1111\/acel.13945. PMID: 35315217; PMCID: PMC9009232.","DOI":"10.1111\/acel.13587"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452226004227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452226004227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:18:47Z","timestamp":1791465527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452226004227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":98,"alternative-id":["S0306452226004227"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.06.032","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting of RhoA-ROCK pathway activators and linked molecular signaling in Alzheimer\u2019s disease: The paving dawn for future therapy","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.06.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Brain Research Organization (IBRO). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}